A Phase 2 Study of Oral Difelikefalin for Moderate-to-Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT). (2022). SKIN The Journal of Cutaneous Medicine, 6(6), s104. https://doi.org/10.25251/skin.6.supp.104